The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Pediatric Vaccines Market Outlook 2024

Global Pediatric Vaccines Market Outlook 2024

Publishing Date : Nov, 2021

License Type :
 

Report Code : 1632887

No of Pages : 136

Synopsis
The global Pediatric Vaccines market was valued at US$ 29730 million in 2020 and is expected to reach US$ 45100 million by the end of 2027, growing at a CAGR of 5.7% during 2021-2027.
This report focuses on Pediatric Vaccines volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Pediatric Vaccines market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Pediatric Vaccines Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

  • Diphtheria
  • Influenza
  • Hepatitis
  • Pneumococcal Diseases
  • Meningococcal Diseases
  • Others

Segment by Application

  • Newborn
  • Infant
  • Child
  • Dolescent

Consumption by Region

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, Other Regions)
  • Europe (Germany, U.K., France, Italy, Russia, Rest of Europe)
  • South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, U.A.E., South Africa, Other Regions)

By Company

  • GlaxoSmithKline
  • Merck
  • Pfizer
  • Sanofi
  • AstraZeneca
  • Novartis
  • Takeda Pharmaceutical
  • Bavarian Nordic
  • Baxter
  • LG Life Sciences
  • Lupin
  • S K Chemicals
  • Mitsubishi Tanabe Pharma
  • Janssen
  • Shenzhen Kangtai Biological Products
  • Sinovac Biotech
  • Bharat Biotech
  • Crucell
  • Dynavax
  • Serum Institute of India

Scope of the Pediatric Vaccines Market Report

Report Metric

Details

Report Name

Pediatric Vaccines Market

Market size in 2021

US$ 29730 Million

The revenue forecast in 2027

US$ 45100 Million

Growth Rate

CAGR of 5.7% from 2021 to 2027

Market size available for years

2020-2027

Forecast units

Value (USD) & Volume (Units)

Segments covered

Types, End-User / Applications, Companies, and Region

Report coverage

Revenue & volume forecast, company share, competitive landscape, growth factors, and trends

Geographic regions covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

Index

1 Pediatric Vaccines Market Overview
1.1 Product Overview and Scope of Pediatric Vaccines
1.2 Pediatric Vaccines Segment by Type
1.2.1 Global Pediatric Vaccines Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Pediatric Vaccines Segment by Application
1.3.1 Global Pediatric Vaccines Sales Comparison by Application: (2021-2027)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Global Pediatric Vaccines Market Size Estimates and Forecasts
1.4.1 Global Pediatric Vaccines Revenue 2016-2027
1.4.2 Global Pediatric Vaccines Sales 2016-2027
1.4.3 Pediatric Vaccines Market Size by Region: 2016 Versus 2021 Versus 2027

2 Pediatric Vaccines Market Competition by Manufacturers
2.1 Global Pediatric Vaccines Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pediatric Vaccines Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pediatric Vaccines Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pediatric Vaccines Manufacturing Sites, Area Served, Product Type
2.5 Pediatric Vaccines Market Competitive Situation and Trends
2.5.1 Pediatric Vaccines Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pediatric Vaccines Players Market Share by Revenue
2.5.3 Global Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Pediatric Vaccines Retrospective Market Scenario by Region
3.1 Global Pediatric Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pediatric Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pediatric Vaccines Market Facts & Figures by Country
3.3.1 North America Pediatric Vaccines Sales by Country
3.3.2 North America Pediatric Vaccines Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pediatric Vaccines Market Facts & Figures by Country
3.4.1 Europe Pediatric Vaccines Sales by Country
3.4.2 Europe Pediatric Vaccines Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pediatric Vaccines Market Facts & Figures by Region
3.5.1 Asia Pacific Pediatric Vaccines Sales by Region
3.5.2 Asia Pacific Pediatric Vaccines Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Pediatric Vaccines Market Facts & Figures by Country
3.6.1 Latin America Pediatric Vaccines Sales by Country
3.6.2 Latin America Pediatric Vaccines Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Pediatric Vaccines Market Facts & Figures by Country
3.7.1 Middle East and Africa Pediatric Vaccines Sales by Country
3.7.2 Middle East and Africa Pediatric Vaccines Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Pediatric Vaccines Historic Market Analysis by Type
4.1 Global Pediatric Vaccines Sales Market Share by Type (2016-2021)
4.2 Global Pediatric Vaccines Revenue Market Share by Type (2016-2021)
4.3 Global Pediatric Vaccines Price by Type (2016-2021)

5 Global Pediatric Vaccines Historic Market Analysis by Application
5.1 Global Pediatric Vaccines Sales Market Share by Application (2016-2021)
5.2 Global Pediatric Vaccines Revenue Market Share by Application (2016-2021)
5.3 Global Pediatric Vaccines Price by Application (2016-2021)

6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Corporation Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.1.4 GlaxoSmithKline Pediatric Vaccines Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Pediatric Vaccines Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pfizer Pediatric Vaccines Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Pediatric Vaccines Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.5.4 AstraZeneca Pediatric Vaccines Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Novartis Pediatric Vaccines Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Takeda Pharmaceutical
6.6.1 Takeda Pharmaceutical Corporation Information
6.6.2 Takeda Pharmaceutical Description and Business Overview
6.6.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Takeda Pharmaceutical Pediatric Vaccines Product Portfolio
6.7.5 Takeda Pharmaceutical Recent Developments/Updates
6.8 Bavarian Nordic
6.8.1 Bavarian Nordic Corporation Information
6.8.2 Bavarian Nordic Description and Business Overview
6.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Bavarian Nordic Pediatric Vaccines Product Portfolio
6.8.5 Bavarian Nordic Recent Developments/Updates
6.9 Baxter
6.9.1 Baxter Corporation Information
6.9.2 Baxter Description and Business Overview
6.9.3 Baxter Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Baxter Pediatric Vaccines Product Portfolio
6.9.5 Baxter Recent Developments/Updates
6.10 LG Life Sciences
6.10.1 LG Life Sciences Corporation Information
6.10.2 LG Life Sciences Description and Business Overview
6.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.10.4 LG Life Sciences Pediatric Vaccines Product Portfolio
6.10.5 LG Life Sciences Recent Developments/Updates
6.11 Lupin
6.11.1 Lupin Corporation Information
6.11.2 Lupin Pediatric Vaccines Description and Business Overview
6.11.3 Lupin Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Lupin Pediatric Vaccines Product Portfolio
6.11.5 Lupin Recent Developments/Updates
6.12 S K Chemicals
6.12.1 S K Chemicals Corporation Information
6.12.2 S K Chemicals Pediatric Vaccines Description and Business Overview
6.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.12.4 S K Chemicals Pediatric Vaccines Product Portfolio
6.12.5 S K Chemicals Recent Developments/Updates
6.13 Mitsubishi Tanabe Pharma
6.13.1 Mitsubishi Tanabe Pharma Corporation Information
6.13.2 Mitsubishi Tanabe Pharma Pediatric Vaccines Description and Business Overview
6.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Product Portfolio
6.13.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.14 Janssen
6.14.1 Janssen Corporation Information
6.14.2 Janssen Pediatric Vaccines Description and Business Overview
6.14.3 Janssen Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Janssen Pediatric Vaccines Product Portfolio
6.14.5 Janssen Recent Developments/Updates
6.15 Shenzhen Kangtai Biological Products
6.15.1 Shenzhen Kangtai Biological Products Corporation Information
6.15.2 Shenzhen Kangtai Biological Products Pediatric Vaccines Description and Business Overview
6.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Product Portfolio
6.15.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.16 Sinovac Biotech
6.16.1 Sinovac Biotech Corporation Information
6.16.2 Sinovac Biotech Pediatric Vaccines Description and Business Overview
6.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Sinovac Biotech Pediatric Vaccines Product Portfolio
6.16.5 Sinovac Biotech Recent Developments/Updates
6.17 Bharat Biotech
6.17.1 Bharat Biotech Corporation Information
6.17.2 Bharat Biotech Pediatric Vaccines Description and Business Overview
6.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Bharat Biotech Pediatric Vaccines Product Portfolio
6.17.5 Bharat Biotech Recent Developments/Updates
6.18 Crucell
6.18.1 Crucell Corporation Information
6.18.2 Crucell Pediatric Vaccines Description and Business Overview
6.18.3 Crucell Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Crucell Pediatric Vaccines Product Portfolio
6.18.5 Crucell Recent Developments/Updates
6.19 Dynavax
6.19.1 Dynavax Corporation Information
6.19.2 Dynavax Pediatric Vaccines Description and Business Overview
6.19.3 Dynavax Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Dynavax Pediatric Vaccines Product Portfolio
6.19.5 Dynavax Recent Developments/Updates
6.20 Serum Institute of India
6.20.1 Serum Institute of India Corporation Information
6.20.2 Serum Institute of India Pediatric Vaccines Description and Business Overview
6.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Serum Institute of India Pediatric Vaccines Product Portfolio
6.20.5 Serum Institute of India Recent Developments/Updates

7 Pediatric Vaccines Manufacturing Cost Analysis
7.1 Pediatric Vaccines Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pediatric Vaccines
7.4 Pediatric Vaccines Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pediatric Vaccines Distributors List
8.3 Pediatric Vaccines Customers

9 Pediatric Vaccines Market Dynamics
9.1 Pediatric Vaccines Industry Trends
9.2 Pediatric Vaccines Growth Drivers
9.3 Pediatric Vaccines Market Challenges
9.4 Pediatric Vaccines Market Restraints

10 Global Market Forecast
10.1 Pediatric Vaccines Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pediatric Vaccines by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pediatric Vaccines by Type (2022-2027)
10.2 Pediatric Vaccines Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pediatric Vaccines by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pediatric Vaccines by Application (2022-2027)
10.3 Pediatric Vaccines Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pediatric Vaccines by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pediatric Vaccines by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Tables

List of Tables
Table 1. Global Pediatric Vaccines Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Pediatric Vaccines Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Pediatric Vaccines Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Pediatric Vaccines Covered in This Study
Table 5. Global Pediatric Vaccines Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Pediatric Vaccines Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Pediatric Vaccines Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Pediatric Vaccines Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Pediatric Vaccines Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Pediatric Vaccines Manufacturing Sites and Area Served
Table 11. Manufacturers Pediatric Vaccines Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Pediatric Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pediatric Vaccines as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Pediatric Vaccines Sales by Region (2016-2021) & (K Units)
Table 16. Global Pediatric Vaccines Sales Market Share by Region (2016-2021)
Table 17. Global Pediatric Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Pediatric Vaccines Sales by Country (2016-2021) & (K Units)
Table 19. North America Pediatric Vaccines Sales Market Share by Country (2016-2021)
Table 20. North America Pediatric Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Pediatric Vaccines Revenue Market Share by Country (2016-2021)
Table 22. Europe Pediatric Vaccines Sales by Country (2016-2021) & (K Units)
Table 23. Europe Pediatric Vaccines Sales Market Share by Country (2016-2021)
Table 24. Europe Pediatric Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Pediatric Vaccines Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Pediatric Vaccines Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Pediatric Vaccines Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Pediatric Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Pediatric Vaccines Revenue Market Share by Region (2016-2021)
Table 30. Latin America Pediatric Vaccines Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Pediatric Vaccines Sales Market Share by Country (2016-2021)
Table 32. Latin America Pediatric Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Pediatric Vaccines Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Pediatric Vaccines Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Pediatric Vaccines Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Pediatric Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Pediatric Vaccines Revenue Market Share by Country (2016-2021)
Table 38. Global Pediatric Vaccines Sales (K Units) by Type (2016-2021)
Table 39. Global Pediatric Vaccines Sales Market Share by Type (2016-2021)
Table 40. Global Pediatric Vaccines Revenue (Million US$) by Type (2016-2021)
Table 41. Global Pediatric Vaccines Revenue Share by Type (2016-2021)
Table 42. Global Pediatric Vaccines Price (USD/Unit) by Type (2016-2021)
Table 43. Global Pediatric Vaccines Sales (K Units) by Application (2016-2021)
Table 44. Global Pediatric Vaccines Sales Market Share by Application (2016-2021)
Table 45. Global Pediatric Vaccines Revenue (Million US$) by Application (2016-2021)
Table 46. Global Pediatric Vaccines Revenue Share by Application (2016-2021)
Table 47. Global Pediatric Vaccines Price (USD/Unit) by Application (2016-2021)
Table 48. GlaxoSmithKline Corporation Information
Table 49. GlaxoSmithKline Description and Business Overview
Table 50. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. GlaxoSmithKline Pediatric Vaccines Product
Table 52. GlaxoSmithKline Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Merck Pediatric Vaccines Product
Table 57. Merck Recent Developments/Updates
Table 58. Pfizer Corporation Information
Table 59. Pfizer Description and Business Overview
Table 60. Pfizer Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Pfizer Pediatric Vaccines Product
Table 62. Pfizer Recent Developments/Updates
Table 63. Sanofi Corporation Information
Table 64. Sanofi Description and Business Overview
Table 65. Sanofi Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Sanofi Pediatric Vaccines Product
Table 67. Sanofi Recent Developments/Updates
Table 68. AstraZeneca Corporation Information
Table 69. AstraZeneca Description and Business Overview
Table 70. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. AstraZeneca Pediatric Vaccines Product
Table 72. AstraZeneca Recent Developments/Updates
Table 73. Novartis Corporation Information
Table 74. Novartis Description and Business Overview
Table 75. Novartis Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Novartis Pediatric Vaccines Product
Table 77. Novartis Recent Developments/Updates
Table 78. Takeda Pharmaceutical Corporation Information
Table 79. Takeda Pharmaceutical Description and Business Overview
Table 80. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Takeda Pharmaceutical Pediatric Vaccines Product
Table 82. Takeda Pharmaceutical Recent Developments/Updates
Table 83. Bavarian Nordic Corporation Information
Table 84. Bavarian Nordic Description and Business Overview
Table 85. Bavarian Nordic Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Bavarian Nordic Pediatric Vaccines Product
Table 87. Bavarian Nordic Recent Developments/Updates
Table 88. Baxter Corporation Information
Table 89. Baxter Description and Business Overview
Table 90. Baxter Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Baxter Pediatric Vaccines Product
Table 92. Baxter Recent Developments/Updates
Table 93. LG Life Sciences Corporation Information
Table 94. LG Life Sciences Description and Business Overview
Table 95. LG Life Sciences Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. LG Life Sciences Pediatric Vaccines Product
Table 97. LG Life Sciences Recent Developments/Updates
Table 98. Lupin Corporation Information
Table 99. Lupin Description and Business Overview
Table 100. Lupin Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Lupin Pediatric Vaccines Product
Table 102. Lupin Recent Developments/Updates
Table 103. S K Chemicals Corporation Information
Table 104. S K Chemicals Description and Business Overview
Table 105. S K Chemicals Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. S K Chemicals Pediatric Vaccines Product
Table 107. S K Chemicals Recent Developments/Updates
Table 108. Mitsubishi Tanabe Pharma Corporation Information
Table 109. Mitsubishi Tanabe Pharma Description and Business Overview
Table 110. Mitsubishi Tanabe Pharma Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Mitsubishi Tanabe Pharma Pediatric Vaccines Product
Table 112. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 113. Janssen Corporation Information
Table 114. Janssen Description and Business Overview
Table 115. Janssen Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Janssen Pediatric Vaccines Product
Table 117. Janssen Recent Developments/Updates
Table 118. Shenzhen Kangtai Biological Products Corporation Information
Table 119. Shenzhen Kangtai Biological Products Description and Business Overview
Table 120. Shenzhen Kangtai Biological Products Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Shenzhen Kangtai Biological Products Pediatric Vaccines Product
Table 122. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 123. Sinovac Biotech Corporation Information
Table 124. Sinovac Biotech Description and Business Overview
Table 125. Sinovac Biotech Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Sinovac Biotech Pediatric Vaccines Product
Table 127. Sinovac Biotech Recent Developments/Updates
Table 128. Bharat Biotech Corporation Information
Table 129. Bharat Biotech Description and Business Overview
Table 130. Bharat Biotech Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Bharat Biotech Pediatric Vaccines Product
Table 132. Bharat Biotech Recent Developments/Updates
Table 133. Crucell Corporation Information
Table 134. Crucell Description and Business Overview
Table 135. Crucell Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Crucell Pediatric Vaccines Product
Table 137. Crucell Recent Developments/Updates
Table 138. Dynavax Corporation Information
Table 139. Dynavax Description and Business Overview
Table 140. Dynavax Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Dynavax Pediatric Vaccines Product
Table 142. Dynavax Recent Developments/Updates
Table 143. Serum Institute of India Corporation Information
Table 144. Serum Institute of India Description and Business Overview
Table 145. Serum Institute of India Pediatric Vaccines Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. Serum Institute of India Pediatric Vaccines Product
Table 147. Serum Institute of India Recent Developments/Updates
Table 148. Production Base and Market Concentration Rate of Raw Material
Table 149. Key Suppliers of Raw Materials
Table 150. Pediatric Vaccines Distributors List
Table 151. Pediatric Vaccines Customers List
Table 152. Pediatric Vaccines Market Trends
Table 153. Pediatric Vaccines Growth Drivers
Table 154. Pediatric Vaccines Market Challenges
Table 155. Pediatric Vaccines Market Restraints
Table 156. Global Pediatric Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 157. Global Pediatric Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 158. Global Pediatric Vaccines Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 159. Global Pediatric Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 160. Global Pediatric Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 161. Global Pediatric Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 162. Global Pediatric Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 163. Global Pediatric Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 164. Global Pediatric Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 165. Global Pediatric Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 166. Global Pediatric Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 167. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Pediatric Vaccines
Figure 2. Global Pediatric Vaccines Market Share by Type in 2020 & 2027
Figure 3. Diphtheria Product Picture
Figure 4. Influenza Product Picture
Figure 5. Hepatitis Product Picture
Figure 6. Pneumococcal Diseases Product Picture
Figure 7. Meningococcal Diseases Product Picture
Figure 8. Others Product Picture
Figure 9. Global Pediatric Vaccines Market Share by Application in 2020 & 2027
Figure 10. Newborn
Figure 11. Infant
Figure 12. Child
Figure 13. Dolescent
Figure 14. Global Pediatric Vaccines Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Pediatric Vaccines Market Size 2016-2027 (US$ Million)
Figure 16. Global Pediatric Vaccines Sales 2016-2027 (K Units)
Figure 17. Global Pediatric Vaccines Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 18. Pediatric Vaccines Sales Share by Manufacturers in 2020
Figure 19. Global Pediatric Vaccines Revenue Share by Manufacturers in 2020
Figure 20. The Global 5 and 10 Largest Pediatric Vaccines Players: Market Share by Revenue in 2020
Figure 21. Pediatric Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 22. Global Pediatric Vaccines Sales Market Share by Region (2016-2021)
Figure 23. Global Pediatric Vaccines Sales Market Share by Region in 2020
Figure 24. Global Pediatric Vaccines Revenue Market Share by Region (2016-2021)
Figure 25. Global Pediatric Vaccines Revenue Market Share by Region in 2020
Figure 26. U.S. Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Canada Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Germany Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. France Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. U.K. Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Italy Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Russia Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. China Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Japan Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. South Korea Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. India Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Australia Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. China Taiwan Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Indonesia Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Thailand Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Malaysia Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Mexico Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Brazil Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Argentina Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Colombia Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Turkey Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Saudi Arabia Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. UAE Pediatric Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Sales Market Share of Pediatric Vaccines by Type (2016-2021)
Figure 50. Sales Market Share of Pediatric Vaccines by Application (2016-2021)
Figure 51. Sales Market Share of Pediatric Vaccines by Application in 2020
Figure 52. Revenue Share of Pediatric Vaccines by Application (2016-2021)
Figure 53. Revenue Share of Pediatric Vaccines by Application in 2020
Figure 54. Manufacturing Cost Structure of Pediatric Vaccines
Figure 55. Manufacturing Process Analysis of Pediatric Vaccines
Figure 56. Pediatric Vaccines Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’